Skip to main content
OpenTrials
Completed

NCT Number: NCT01233401

Tdap Vaccination for Infant Caregivers

This study evaluates whether offering Tetanus, diphteria and acellular pertussis (Tdap) vaccine to caregivers of newborn infants during pediatric well child visits increase the caregivers' vaccination rates.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–64 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Hospital of St. Raphael

New Haven, Connecticut, 06511, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18-64 years old
  • English or Spanish speaking

Exclusion criteria

  • Do not speak English or Spanish

Treatment and study plan

Survey

Other

Mothers and Other infant caregivers are surveyed at the end of the 2 week newborn well child visit about whether they chose to receive the Tdap vaccine at the pediatrician's office.

Primary outcomes

  1. Maternal Tdap Vaccination Rate

    Time frame: At 2 week well child visit

Secondary outcomes

  1. Other Infant Caregiver Tdap Vaccination Rate

    Time frame: At 2 week well child visit

Sponsors and collaborators

Lead sponsor

Yale University

Other

Collaborators

  • Saint Raphael Healthcare System

Registry information

Official study title

Tdap Vaccination for Infant Caregivers in the Pediatric Office

Important dates

Study start
2010
Primary completion
2010
Study completion
2011
First posted
Nov 3, 2010
Registry last updated
Jul 28, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.